Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05195489 · ClinicalTrials.gov registry record · NA
Examining the Impact of Family Connectors
A NA study of Caregiver Stress Syndrome, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
- 1
- Study location
NCT05195489: Completed NA study of Caregiver Stress Syndrome, sponsored by NYU Langone Health.
NCT05195489 is a NA study of Caregiver Stress Syndrome that has completed, run by NYU Langone Health. The registered enrollment target is 28 participants, below the 258-participant average among 3 other Caregiver Stress Syndrome trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05195489, a NA study of Caregiver Stress Syndrome, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to understand the impact of Family Connectors, a peer-to-peer support and education program for family members who have participated in OnTrackNY, a treatment program for adolescents and young adults.
Primary Outcome
Perceived social support is measured by a 13-item self-reported questionnaire. The subject is asked to rate each statement about social support on a scale of 1-7 (1=very strongly disagree, 2=strongly disagree, 3=disagree, 4=neither agree nor disagree, 5=agree, 6=strongly agree, 7=very strongly agree). Scores range from 13-91. Higher scores indicate stronger social support.
Conditions Studied
Interventions
- OTHER Family Connectors
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2022-03-07 |
| Est. Completion | 2024-11-11 |
| Phase | NA |
What the finished NCT05195489 record still lists
NCT05195489 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 258-participant average among 3 other Caregiver Stress Syndrome trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Caregiver Stress Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Family Connectors is the first listed.
NCT05195489 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05195489 about?
NCT05195489 is a clinical study titled "Examining the Impact of Family Connectors". The purpose of this study is to understand the impact of Family Connectors, a peer-to-peer support and education program for family members who have participated in OnTrackNY, a treatment program for adolescents and young adults.
What is the current status of trial NCT05195489?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2022-03-07. Estimated completion is 2024-11-11.
What conditions does trial NCT05195489 study?
This clinical trial studies the following conditions: Caregiver Stress Syndrome.
What interventions are being tested in trial NCT05195489?
The interventions under investigation include: Family Connectors (OTHER).
Who is sponsoring clinical trial NCT05195489?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05195489 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Caregiver Stress Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI